Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
xB3-001 is the lead program at Bioasis and is an xB3 peptide vector-trastuzumab fusion. Trastuzumab is sold under the brand name Herceptin. There's a good summary of the lead program and pre-clinical data in the recent corporate update presentation.